BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2018
View Archived Issues
Aduro earns milestone from Merck & Co. for initiation of phase I trial of anti-CD27 antibody
Read More
Caladrius Biosciences acquires license to late-stage CD34+ cell therapy program from Shire
Read More
Eisai and Purdue Pharma report results from clinical studies of lemborexant
Read More
Pivotal phase III study of bempedoic acid in ASCVD meets primary endpoint
Read More
Vocimagene amiretrorepvec/5-fluorocytosine granted E.U. orphan designation for glioma
Read More
Researchers evaluate safety and immunogenicity of a new anti-allergic vaccine
Read More
MD Anderson Cancer Center and Berkeley Lights launch new company
Read More
Phase IIb study of BTK inhibitor in MS meets primary endpoint
Read More
Oxford Vacmedix closes series A funding to develop its two lead cancer vaccine candidates
Read More
NTP-42 receives E.U., U.S. orphan designations for pulmonary arterial hypertension
Read More
Compugen licenses SUREtechnology platform from Selexis
Read More
Antimicrobial polymers show killing activity without leading to resistance
Read More
University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists
Read More
Novel NF-kappaB inhibitors synthesized at University College Dublin
Read More
Arena Pharmaceuticals patents new 5-HT2C receptor agonists
Read More
Genoimmune Therapeutics creates novel human leukocyte antigen-binding polypeptides
Read More
New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University
Read More
Evotec and Sanofi in negotiations over new open innovation platform in infectious disease
Read More
Eisai and Merck & Co. agree on strategic collaboration for Lenvima
Read More
Harbin Medical University presents data on PET tracer for EGFR mutation determination
Read More
Immuron announces topline phase II results for IMM-124E in NASH
Read More
MuSK stimulation preserves neuromuscular synapses in amyotrophic lateral sclerosis
Read More
Medicure to commercialize Zydus Cadila's pitavastatin in U.S.
Read More
Daiichi Sankyo initiates phase II study of DS-8201 in HER2-expressing colorectal cancer
Read More
Aevi Genomic Medicine and Kyowa Hakko Kirin expand collaboration
Read More
